Compare
Labcorp vs Sotera Health (LH vs SHC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Labcorp (LH) returned +46.2% and Sotera Health (SHC) +1.3%; so far this year the figures are +46.1% and -9.2%.
Labcorp is the larger company by market value, about 6.5 times the size of Sotera Health.
On trailing earnings, LH trades at 30.1 times and SHC at 26.7 times.
Revenue grew +6.0% at LH and +6.9% at SHC over the last year.
LH yields 0.79%. SHC pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| LH | SHC | |
|---|---|---|
| Price | $366.57 | $16.01 |
| 1-day | +0.90% | +0.88% |
| YTD | +46.11% | -9.24% |
| 1 year | +46.22% | +1.27% |
| 3 years | +79.74% | +24.40% |
| Market cap | $29.8B | $4.6B |
| P/E | 30.1 | 26.7 |
| P/S | 2.04 | 3.72 |
| P/B | 3.36 | 6.24 |
| Revenue growth | +6.00% | +6.90% |
| EPS growth | +19.60% | +200.00% |
| Gross margin % | 29.0 | 54.6 |
| Net margin % | 6.9 | 14.1 |
| ROE % | 11.3 | 23.7 |
| Debt / equity | 0.66 | 2.91 |
| FCF yield % | 4.3 | 3.0 |
| Dividend yield % | 0.79 | — |
| Beta | 0.38 | 0.96 |
| RSI (14) | 69.9 | 31.2 |
| Technical rating |